London, 02 January 2015 – TechNavio has announced the publication of a new market research report on the Global Prenatal and Newborn Genetic Testing Market, which is expected to grow at a CAGR of 31.91 percent from 2015-2019.
About the Report
The report highlights the launch of several new products, which has affected overall market growth. In 2014, Laboratory Corporation of America Holdings launched the informaSeq Prenatal Test and Sequenom launched the VisibiliT laboratory-developed test in international markets.
“The launch of new tests has had a positive impact on the Global Prenatal and Newborn Genetic Testing Market, which will further drive market growth in the coming years,” says Faisal Ghaus, Vice President of TechNavio.
Vendors in the market are also taking advantage of opportunities such as strategic alliances and mergers and acquisitions, in order to increase their market share. In March 2014, Good Start Genetics announced a collaboration with PerkinElmer for GoodStart Select Carrier Screening Tests to broaden the Global Women’s Health Market.
“The market is highly fragmented in nature because of the presence of extremely competitive vendors like Agilent Technologies, Bio-Rad Laboratories, Illumina and Sequenom, and this is expected to help it flourish over the next four years.”
Key Information Covered in the Report:
Market segmentation, size and forecast through 2019
Market Growth Drivers:
- Growing Incidences of Fetal Health-related Abnormalities
- For a full detailed list, view our report.
Market Challenges:
- Decrease in Fertility Rates
- For a full detailed list, view our report.
Market Trends:
- Increase in Number of New Product Launches
- For a full detailed list, view our report.
Key Vendors:
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Sequenom Inc.
Other Prominent Vendors:
- Angle
- BGI Health
- Biogen Idec
- CellScape
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
